Comment on "visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate"

Journal of Clinical Rheumatology

Volumn 19, Issue 3, 2013, Pages 165-

  Guirao Arrabal, Emilio ^a   García Olid, Beatriz ^a   Muñoz López, Carlos ^a   Fernández De La Puebla Giménez, Rafael Ángel ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADVERSE OUTCOME; BONE MARROW BIOPSY; DRUG SAFETY; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEISHMANIA; LETTER; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROLOGY; SUPERINFECTION; VISCERAL LEISHMANIASIS;

ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEISHMANIA; LEISHMANIASIS, VISCERAL; METHOTREXATE;

EID: 84876171652     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318289e7e3     Document Type: Letter

References (2)

1. Karagiannidis GS, Mantzourani M, Meletis J, et al. Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate. J Clin Rheumatol. 2012;18:59.
2. Garcia Olid B, Guirao Arrabal E, Alcala Diaz JF, et al. Visceral leishmaniasis in two patients treated with methotrexate for rheumatoid arthritis [In Spanish]. Enferm Infecc Microbiol Clin. 2012;30:52.